Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study
- 30 September 2010
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 11 (9), 827-834
- https://doi.org/10.1016/s1470-2045(10)70167-4
Abstract
No abstract availableKeywords
Funding Information
- Korean Seoul City Research (10526)
- the National Research and Development Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (0920330)
This publication has 36 references indexed in Scilit:
- Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and ImmunosuppressionClinical Gastroenterology and Hepatology, 2009
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without RituximabJournal of Clinical Oncology, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypesBlood, 2008
- Hematopoietic Malignancies Associated with Viral and Alcoholic HepatitisCancer Epidemiology, Biomarkers & Prevention, 2008
- Hepatitis C virus and lymphomaJournal of Clinical Pathology, 2006
- Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic StudiesCancer Epidemiology, Biomarkers & Prevention, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Epidemiology of Hepatitis C Virus in KoreaIntervirology, 2005